| The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells A Marçais, J Cherfils-Vicini, C Viant, S Degouve, S Viel, A Fenis, ... Nature immunology 15 (8), 749-757, 2014 | 565 | 2014 |
| Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma S Platonova, J Cherfils-Vicini, D Damotte, L Crozet, V Vieillard, P Validire, ... Cancer research 71 (16), 5412-5422, 2011 | 510 | 2011 |
| Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance J Cherfils-Vicini, S Platonova, M Gillard, L Laurans, P Validire, ... The Journal of clinical investigation 120 (4), 1285-1297, 2010 | 260 | 2010 |
| TRF2-mediated control of telomere DNA topology as a mechanism for chromosome-end protection D Benarroch-Popivker, S Pisano, A Mendez-Bermudez, L Lototska, ... Molecular cell 61 (2), 274-286, 2016 | 169 | 2016 |
| Tumor microenvironment is multifaceted C Sautès-Fridman, J Cherfils-Vicini, D Damotte, S Fisson, WH Fridman, ... Cancer and Metastasis Reviews 30, 13-25, 2011 | 148 | 2011 |
| TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells A Biroccio, J Cherfils-Vicini, A Augereau, S Pinte, S Bauwens, J Ye, ... Nature cell biology 15 (7), 818-828, 2013 | 127 | 2013 |
| Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer P Hofman, J Cherfils-Vicini, M Bazin, M Ilie, T Juhel, X Hébuterne, ... Cancer research 75 (5), 835-845, 2015 | 124 | 2015 |
| TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non–small cell lung cancer S Chatterjee, L Crozet, D Damotte, K Iribarren, C Schramm, M Alifano, ... Cancer research 74 (18), 5008-5018, 2014 | 105 | 2014 |
| The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression KD Wagner, J Cherfils-Vicini, N Hosen, P Hohenstein, E Gilson, ... Nature communications 5 (1), 5852, 2014 | 96 | 2014 |
| NKG2C is a major triggering receptor involved in the Vδ1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells H Fausther-Bovendo, N Wauquier, J Cherfils-Vicini, I Cremer, P Debré, ... Aids 22 (2), 217-226, 2008 | 71 | 2008 |
| Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF 2 J Cherfils‐Vicini, C Iltis, L Cervera, S Pisano, O Croce, N Sadouni, ... The EMBO journal 38 (11), e100012, 2019 | 64 | 2019 |
| A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy L Douguet, S Janho dit Hreich, J Benzaquen, L Seguin, T Juhel, ... Nature Communications 12 (1), 653, 2021 | 53 | 2021 |
| Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation A Mousset, E Lecorgne, I Bourget, P Lopez, K Jenovai, J Cherfils-Vicini, ... Cancer Cell 41 (4), 757-775. e10, 2023 | 45 | 2023 |
| TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment P Zizza, R Dinami, M Porru, C Cingolani, E Salvati, A Rizzo, C D’Angelo, ... Nucleic acids research 47 (7), 3365-3382, 2019 | 44 | 2019 |
| Characterization of immune functions in TRAF4‐deficient mice J Cherfils‐Vicini, B Vingert, A Varin, E Tartour, WH Fridman, ... Immunology 124 (4), 562-574, 2008 | 37 | 2008 |
| Neutrophils: mediating TelOxidation and senescence MS Jacome Burbano, J Cherfils‐Vicini, E Gilson The EMBO Journal 40 (9), e108164, 2021 | 14 | 2021 |
| Nitric oxide synthase 2 improves proliferation and glycolysis of peripheral γδ T cells L Douguet, J Cherfils-Vicini, L Bod, R Lengagne, E Gilson, ... PLoS One 11 (11), e0165639, 2016 | 13 | 2016 |
| A novel pathway links telomeres to NK-cell activity: Implications for immunotherapy J Cherfils-Vicini, P Zizza, E Gilson, A Biroccio Oncoimmunology 3 (2), e27358, 2014 | 13 | 2014 |
| Inhibiting TRF 1 upstream signaling pathways to target telomeres in cancer cells J Cherfils‐Vicini, E Gilson EMBO molecular medicine 11 (7), e10845, 2019 | 11 | 2019 |
| A novel screen for expression regulators of the Telomeric protein TRF2 identified small molecules that impair TRF2 dependent immunosuppression and tumor growth M El Maï, S Janho dit Hreich, C Gaggioli, A Roisin, N Wagner, J Ye, ... Cancers 13 (12), 2998, 2021 | 9 | 2021 |
